H. R. 1899 

One Hundred Seventeenth Congress 

of the 

United States of America 

AT THE FIRST SESSION 

Begun and held at the City of Washington on Monday, 

the fourth day of January, two thousand and twenty-one 

An Act 

To amend the Controlled Substances Act to provide for the modification, transfer, 

and termination of a registration to manufacture, distribute, or dispense controlled 

substances or list I chemicals, and for other purposes. 

Be it enacted by the Senate and House of Representatives of 

the United States of America in Congress assembled, 

SECTION 1. SHORT TITLE. 

This Act may be cited as the ‘‘Ensuring Compliance Against 

Drug Diversion Act of 2021’’. 

SEC. 2. MODIFICATION, TRANSFER, AND TERMINATION OF REGISTRATION TO MANUFACTURE, DISTRIBUTE, OR DISPENSE CONTROLLED SUBSTANCES. 

Subsection (a) of section 302 of the Controlled Substances Act 

(21 U.S.C. 822) is amended by adding at the end the following 

new paragraph: 

‘‘(3)(A) Except as provided in subparagraph (C), the registration 

of any registrant under this title to manufacture, distribute, or 

dispense controlled substances or list I chemicals terminates if 

and when such registrant— 

‘‘(i) dies; 

‘‘(ii) ceases legal existence; 

‘‘(iii) discontinues business or professional practice; or 

‘‘(iv) surrenders such registration. 

‘‘(B) In the case of such a registrant who ceases legal existence 

or discontinues business or professional practice, such registrant 

shall promptly notify the Attorney General in writing of such fact. 

‘‘(C) No registration under this title to manufacture, distribute, 

or dispense controlled substances or list I chemicals, and no 

authority conferred thereby, may be assigned or otherwise transferred except upon such conditions as the Attorney General may 

specify and then only pursuant to written consent. A registrant 

to whom a registration is assigned or transferred pursuant to the 

preceding sentence may not manufacture, distribute, or dispense 

controlled substances or list I chemicals pursuant to such registration until the Attorney General receives such written consent. 

‘‘(D) In the case of a registrant under this title to manufacture, 

distribute, or dispense controlled substances or list I chemicals 

desiring to discontinue business or professional practice altogether 

or with respect to controlled substances and list I chemicals (without 

assigning or transferring such business or professional practice 

to another entity), such registrant shall return to the Attorney 

General for cancellation— 

‘‘(i) the registrant’s certificate of registration; 
H. R. 1899—2 

‘‘(ii) any unexecuted order forms in the registrant’s possession; and 

‘‘(iii) any other documentation that the Attorney General 

may require.’’. 

SEC. 3. DETERMINATION OF BUDGETARY EFFECTS. 

The budgetary effects of this Act, for the purpose of complying 

with the Statutory Pay-As-You-Go Act of 2010, shall be determined 

by reference to the latest statement titled ‘‘Budgetary Effects of 

PAYGO Legislation’’ for this Act, submitted for printing in the 

Congressional Record by the Chairman of the House Budget Committee, provided that such statement has been submitted prior 

to the vote on passage. 

Speaker of the House of Representatives. 

Vice President of the United States and

President of the Senate.